Shareholders Filed a Lawsuit Against Zynex for Inflating Revenue Through Billing Schemes

Court: D. Colorado

Case: 1:25-cv-00913

On March 20, 2025, ZYXI shareholders have filed a class action against Zynex, accusing it of inflating revenue by sending excessive supplies to patients and billing insurers.

What is this lawsuit about?

On March 11, 2025, Zynex revealed a revenue shortfall and that Tricare had suspended payments while reviewing past claims—causing ZYXI to drop 51.3%. This came after a June 2024 exposé reported Zynex routinely oversupplied patients with unrequested products like batteries and electrode pads, triggering insurer scrutiny and removals from networks.

Following this, ZYXI dropped 51.3%.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify ZYXI investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.